About Technology Issues FAQ

Links

Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer

Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.